Reports for SANDOZ IRBESARTAN HCT

Brand name

SANDOZ IRBESARTAN HCT

Company Name
SANDOZ CANADA INCORPORATED
Drug Identification Number
02337436
Ingredients
HYDROCHLOROTHIAZIDE
IRBESARTAN
Ingredient Strength
12.5 MG
300 MG
ATC Code
C09DA
C09DA
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Status
MARKETED
Shortage reports
Packaging sizes (GTIN) Additional packaging sizes Status Date Created Date Updated Reports
No GTINs available 100 Resolved 2019-03-05 2020-07-20 77655
No GTINs available 500 Resolved 2019-04-01 2020-06-22 80194
No GTINs available 100FCT BO CA Resolved 2020-09-21 2020-10-27 124609
No GTINs available 500FCT BO CA Resolved 2020-09-21 2020-10-27 124612
No GTINs available 100FCT Resolved 2023-03-06 2023-03-28 186285
No GTINs available 100FCT BO Resolved 2023-08-07 2023-08-15 201264
No GTINs available 500FCT Resolved 2023-12-04 2024-01-18 212445
No GTINs available 500FCT Resolved 2024-09-16 2024-10-15 237750
No GTINs available 100FCT Resolved 2024-10-28 2024-12-11 241400
No GTINs available 500FCT Actual shortage 2025-01-27 2025-03-10 248642

Showing 1 to 10 of 10

Discontinuation reports
Packaging sizes (GTIN) Additional packaging sizes Status Date Created Date Updated Reports

Showing 1 to 0 of 0